Medical News

RSS

Whitehead researchers develop new type of genetic screen for human cells

Whitehead researchers have developed a new type of genetic screen for human cells to pinpoint specific genes and proteins used by pathogens, according to their paper in Science.

27 Nov 2009

SHH grants stock options by an aggregate of 8,644,375 common shares

Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) announces that its Board of Directors has granted stock options to nine directors and officers in respect of an aggregate of 8,644,375 common shares. In addition, Sonomax has granted stock options to an aggregate of 20 employees and consultants, including one investor-relations consultant, in respect of an aggregate of 5,098,750 common shares.

27 Nov 2009

CIHI study shows number of practicing physicians in Canada has increased by 8%

The number of practising physicians in Canada increased at a faster rate than the population over the past five years, according to a new study released today by the Canadian Institute for Health Information (CIHI).

27 Nov 2009

ALDA Pharmaceuticals and Shoppers Drug Mart sign distribution agreement

ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("the Company" or "ALDA") announces that it has entered into an agreement with Shoppers Drug Mart Corporation ("Shoppers") that will make the Company's T36® Antiseptic Hand Sanitizer available in over 1,170 Shoppers Drug Mart and Pharmaprix stores across Canada.

26 Nov 2009

Experts say vitamin D assists body's immune system to fight against H1N1

The world's leading vitamin D experts say that raising your levels of "the sunshine vitamin" this winter might be the best way to help your body naturally raise its resistance to all forms of the flu virus - including the H1N1 swine flu virus.

26 Nov 2009

CyberKnife Robotic Radiosurgery treatment offers new option for cancer patients in Ontario

Ontario marks a milestone with the announcement of the province's first CyberKnife Robotic Radiosurgery treatment option for cancer patients at Juravinski Cancer Centre. The technology will offer many cancer patients an effective alternative to surgery for some cancers.

26 Nov 2009

Microban line of hand sanitizers launched by Noveko International

Noveko International Inc. ("the Company") is pleased to announce the launch of its new Microban(R) line of hand sanitizers. The hand sanitizers formerly marketed under the AZURO(TM) brand are now sold under the Microban(R) brand name, pursuant to the terms of the August 2009 agreement with Microban International, Ltd. ("Microban"), the global leader in built-in antimicrobial product protection.

26 Nov 2009

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

MICARDIS(R) (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor.

26 Nov 2009

Summary of third-quarter financial results released by BioSyent

BioSyent Inc. ("BioSyent")today released a summary of its 2009 third quarter financial results.

26 Nov 2009

Local parents and pre-school children join Tom Cochrane to launch World Vision's Five for 5 campaign

The World Vision clinic, modeled after a typical African community clinic, will stand in sharp contrast to the now-common sight of parents and children receiving the care they need at Canadian H1N1 flu shot clinics.

26 Nov 2009

International collaborative research projects to decipher the biology behind the ageing process

Research efforts to help the world's ageing population live longer healthier lives have been given a major boost with the announcement of six new transatlantic research projects aiming to understanding the biology of the ageing process.

26 Nov 2009

OSEO awards fund for Galapagos NV's antibody therapeutics program

Galapagos NV announces that its antibody therapeutics program with MorphoSys and SARM program have been awarded funding by the French governmental organization OSEO.

26 Nov 2009

Breast Cancer Campaign awards a three year project grant to Cambridge scientist

Individualised treatment for each breast cancer patient could soon become a reality, according to Breast Cancer Campaign.

26 Nov 2009

Study on response to breast cancer radiotherapy

Scientists are closer to discovering why some people respond to breast cancer radiotherapy better than others, according to Breast Cancer Campaign.

26 Nov 2009

Melvin R. Kaplan to be honored for his lifetime devotion to the care of patients

Melvin R. Kaplan, MD, FACP, a former Board Chair and one of the founders of the research institute that became Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), will be honored by the American College of Physicians for his lifetime devotion to the care of patients.

26 Nov 2009

GE Healthcare, MTL partner to manufacture diagnostic imaging products in Russia

GE Healthcare, a unit of General Electric Company, and a leading Russian medical imaging manufacturer Medical Technologies Limited (MTL), today announced a strategic partnership to manufacture diagnostic imaging products in Russia, starting with GE Healthcare’s CT BrightSpeed™ Elite system, in line with GE’s healthymagination strategy. The partnership will see Russia’s first locally manufactured advanced 16-slice computed tomography (CT).

26 Nov 2009

GE Healthcare’s flagship Discovery CT750HD system installed in Moscow

GE Healthcare, a unit of General Electric Company, today announced the installation of Russia’s first high-definition computed tomography (CT) scanner, GE Healthcare’s flagship Discovery CT750HD, at the Center of Medical Rehabilitation by the Russian Ministry of Health in Moscow led by Professor Konstantin V. Lyadov.

26 Nov 2009

Prescriptions for cholestrol therapy filled after the release of Arbiter 6-HALTS study results

In the week ending Friday, Nov. 20 – after the American Heart Association and New England Journal of Medicine released results of the Arbiter 6-HALTS study on Saturday, Nov. 14 – patients new to Niaspan filled 13,255 prescriptions for the cholesterol therapy, an increase of 41% from the week ending Nov. 13.

26 Nov 2009

MUHC's innovative treatment for HIV patients passes first clinical trial successfully

An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. S-kaly from the Universit- de Montr-al.

26 Nov 2009

Comparable indicators on long-term care

Even before the current financial crisis, there was a growing concern over the fiscal and social sustainability of long-term care for dependent older people. Yet despite these concerns, little is known about basic indicators on this subject. The present publication, "Facts and Figures on Long-term Care - Europe and North America" seeks to bridge that gap of information by bringing together information from international and national sources to present comparable indicators on long-term care.

26 Nov 2009